Several reports discuss the use of weight-loss injections such as Mounjaro (and Wegovy) in the UK and note that some people experience less than expected results. The articles claim that experts have identified a supplement—described as costing “7p”—that may be taken alongside these medicines. According to the reports, the supplement is presented as potentially “turbo-charging” effects on weight outcomes for people using anti-obesity injections and as also helping reduce cholesterol levels. The coverage also emphasizes that many patients may be unaware of the supplement and frames it as a way to reduce the likelihood of regaining weight after initial loss.
Across the sources provided, the central points are that anti-obesity drugs are widely used, that responses vary among patients, and that the supplement is presented as an add-on that could support both weight management and cholesterol improvement. The articles, however, do not provide detailed clinical data within the provided excerpts. The claims remain framed as expert guidance in the reports.
